In a subgroup analysis according to the localisation of CD8+ T cells, patients with a high density of CD8+ T cells in the intraepithelial region of the tumour were more likely to have a good PFS than those with a high density of CD8+ T cells in the tumour stroma. This evidence concerns the gene CD8A and neoplasm.